This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Matt Miller
Principal Scientist at Codexis


Mathew Miller is a Principal Scientist in Molecular and Cellular Engineering at Codexis, where he has led protein engineering efforts for Life Sciences. These include directed evolution projects for T7 RNA polymerase, next-generation sequencing enzymes, and enzymatic DNA synthesis. He is currently focused on enzymes used in mRNA manufacturing.

Agenda Sessions

  • Engineered Enzymes to Overcome Scalability and Sustainability Challenges of Nucleic Acid Therapeutics Manufacturing